Cell transplantation models / BT-549 / BT-549 orthotopic fat pad (parental dose not locked)

BT-549 orthotopic fat pad (parental dose not locked)

Breast carcinoma · MC-h029

Use cases

Parental orthotopic mammary fat-pad dose is not locked to a PubMed-checkable default SOP. Pilot required. Do not copy s.c. 5×10⁷.

Catalog: MC-h029 · Product modeling page

RUO. IACUC and SPF required. Cell number/volume/anesthetic follow this protocol’s compound card and PMIDs—do not copy MDA-MB-231. IACUC may override published anesthetic numbers. Not a substitute for the veterinary SOP.

Use-case overview

Honestly marks not locked; s.c. is another protocol.

UseFitPrimary readoutNotes
Parental orthotopicNot recommended—Dose not locked.
5×10⁷ s.c. CDXRecommendedSee s.c. protocolUse the s.c. page.

Does the workflow match?

Unlocked orthotopic and s.c. are not interchangeable.

Usevs foolproof SOPDifferences vs core SOP
Orthotopic (unlocked)Other routePilot required.
s.c. CDXSame core SOP5×10⁷ ♀ BALB/c nude[1].

Host spec

Orthotopic parental not locked.

Indication / contextSexStrain / hostNotes
Orthotopic♀ / per IACUCNot lockedPilot.

In one line

Pilot → lock SOP.

D−1 / D0 timeline

  1. 1. D−7 to D−3

    Quarantine; confirm sex/strain/endpoints and IACUC.

  2. 2. D−1

    Feed at 80–90% confluence.

  3. 3. D0

    Inoculate per the recipe card (原位:亲本剂量未锁).

  4. 4. After

    Follow the monitor log; stop at endpoints.

Protocol overview

Scenario-specific flowchart (core engraftment skeleton with host/therapy or imaging/readout changes).

  1. Pilot
  2. Fix passage
  3. —

Novice pack (literature cases)

Flowchart buttons open the matching table. Full pack below, in use order.

Unpack list (plan per mouse)

SKUs link to catalog items. Follow the MC-h029 datasheet for medium. Matrigel only if the compound card lists it. Anesthetic: compound card/PMID; IACUC may override.[1]

ItemPer mouse / studyNotes
BT-549 cells MC-h029Start from 1 vialSTR / mycoplasma-qualified; log passage
FBS MC100Complete medium per datasheetPrefer regular grade
Ca²⁺/Mg²⁺-free PBS / serum-free mediumResuspend; volume on the recipe cardPer SOP
T75 or 10-cm dishSee expansion tableLog-phase harvest; T75 yield planned at ~5×10⁶, not a measured lot value
Matrigel (only if this protocol uses it)Per compound cardOn ice; skip if not listed
Syringe / needle1 per mouse + sparesGauge on the inject card and the paper

Expansion cases: mice vs T75

按本协议出现的最高细胞数 5e+7 规划; dead-space ×1.2. Do not reuse MDA-MB-231 orthotopic 2×10⁶ math.

AnimalsT75 flasks
112
224
336
448
560
672
784
896
9108
10120

Inoculum recipe

This SOP dose string: 原位:亲本剂量未锁. Batch ×1.2 for dead space; load one syringe per animal.[1]

ItemThis SOPNotes
Cells / volume原位:亲本剂量未锁Follow the paper’s Methods; pilot n=3–5
MatrixOnly if the compound card lists itDo not copy another line’s 1:1 or 25%
WindowOn ice; finish promptly (often 30–60 min)Resuspend or discard if delayed
Viability≥90% singles<90% or clumped: do not inject

Injection / surgery checklist

Follow published parameters for this line—do not copy other lines. Anesthetic: compound card/PMID; IACUC may override.

CheckPassIf fail
RouteMatch the name/IACUC SOPUnsure: read the PMID; do not guess
Air / clumpsNo air; singles on the scopeClumped: do not inject

Culture card (BT-549 / MC-h029)

Inverted microscope (schematic 10× field): confluence is the % of the growth surface covered by cells. If the monolayer is even, that matches the fraction of the field occupied. Split/harvest at the middle panel. Click the schematic to enlarge.

~50% (too sparse)
Large gaps; wait one more day
85–90% (split / harvest)
Nearly full, small gaps; no stacking
~100% (overgrown)
No gaps; do not inject
Click to enlarge

Follow the datasheet. Confluence = % of growth area covered; schematic, not a real micrograph.[1]

ItemPractice
MediumDatasheet first (MC-h029). Feed before harvest as usual for this line.
Doubling time~3.7 days (Cellosaurus; not a measured lot)
80–90% confluence (harvest)Nearly full with small gaps; no stacking. Too sparse for yield; a packed monolayer should not be injected.
PassageFix an early–mid window for in-vivo work; validate labeled lines.
Day −1Feed; check morphology; expand enough T75s.

What success looks like (expected, not a guarantee)

Kinetics vary by strain, passage, and dose—pilot first. Troubleshoot before raising cell number.[1]

Time pointTypical appearance
Day 0Route checks passed; active after recovery
Follow-up windowPer pilot design.
TakeLots vary; pilot n≈3–5

Troubleshooting

Welfare issues follow the IACUC SOP—do not improvise doses or anesthetic concentrations from this page.

SignLikely causeAction
Clumps / clogged needleIncomplete dissociation or gel setDo not inject; re-ice or discard
Failed-route signsLeak or wrong planeDrop from the primary analysis; use the checklist
No readout in the windowMissed inject, dead cells, wrong dose/hostAudit the log and the paper; do not copy another line’s dose
Weight drop / distress / ulcerBurden or surgical complicationHumane endpoint now

Monitoring log fields

Often no caliper volumes on this route. Weight and IACUC endpoints outrank the image.

FieldHow to log
Date / D0Inoculation day
Mouse / arm / passageLock IDs after randomization
Route successY/N (reason if no)
Body weight (g)Same day as observations; sharp drop triggers endpoint
ReadoutPer pilot design.

Literature case comparison

Rows are this protocol’s references only—other lines’ Methods numbers are not copied in. Open the PMID.

PaperYearJournalHow to use
—Parental orthotopic fat padDose not lockedPilot required
  1. 01
    [Note] Parental orthotopic dose not locked.
  2. 02
    [Contrast] s.c. 5×10⁷ is on the other protocol[1].

Reagents / materials

ItemRoleConc. / dose
BT-549 cells (MC-h029)Inoculum原位:亲本剂量未锁
Anesthetic / analgesicSurgery & welfare按批件
Test drug / vehicle (optional)Treatment arm按药理方案

Readouts

Per pilot design.

References (PubMed)

  1. [1]PMID 41307753 — Lon peptidase 1 promotes proliferation and metastasis in breast cancer via interleukin 6 signaling. Discov Oncol (2025)

Disclaimer: RUO; IACUC required. Optimize by strain and pilot. Red tags mark weak or non-metastatic parental endpoints.

Other protocols

← Back to line index

Disclaimer: Research use only (RUO). Not clinical guidance or a substitute for institutional animal SOPs. In vivo work requires ethics approval. Inline [n] maps to each section’s reference list.